blindness from semaglutide May Be Linked to Condition That Causes Does Semaglutide Use Lead to

These can include nausea, vomiting, diarrhea, constipation, reflux, reduced appetite, and abdominal discomfort

It is reasonable to take both observations seriously as hypotheses, with two cautions: Phase 2 trials are smaller, and the trial populations are not identical to GLP-1 trial populations

Severe abdominal pain, persistent vomiting, dehydration, breathing problems, facial swelling, or other serious symptoms require prompt medical attention

That said, its important to note: there is no direct head-to-head clinical trial between Tirzepatide and Retatrutide yet

Many insurers still classify Ozempic as a "non-essential" or "lifestyle" drug when used for obesity, even though the American Medical Association and CDC recognize obesity as a chronic disease